Recent Finacing
Recent Raise
TCRyption develops T‑cell receptor (TCR‑T) cellular immunotherapies using its TCRypt platform to mine physiologically relevant TCRs, build a TCR bank, and expand therapies across HLA alleles and tumor types.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
